Merck Scientific Webinar
Novel Antibiotics and their Place in Therapy in the Intensive Care Unit
Objectives for the webinar:
- Review the Role of Newly Approved Antimicrobials in Canada in the Treatment of Hospital Acquired and Ventilator Associated Bacterial Pneumonia (primary objective)
- Describe the prevalence, risk factors and impact of nosocomial infections and the most common causative pathogens in the intensive care unit (ICU)
- Discuss Antimicrobial Resistance and Antimicrobial Stewardship during a pandemic
Speakers AND MODERATORS:
Dr. Anand Kumar
Dr Anand Kumar is a Professor of Medicine (Critical Care Medicine and Infectious Diseases), Medical Microbiology and Pharmacology/Therapeutics at the University of Manitoba and an attending physician at the Health Sciences Centre and St. Boniface Hospital, Winnipeg, Manitoba, Canada. He earned his medical degree from the University of Toronto in Ontario, Canada and completed his residency in Internal Medicine at the Toronto Hospital—University of Toronto. Dr Kumar subsequently completed Fellowships in Critical Care Medicine and Cardiovascular Research at Rush-Presbyterian-St Luke’s Medical Center in Chicago and Infectious Diseases at the University of Wisconsin Hospital and Clinics in Madison, Wisconsin. Dr. Kumar is trained in Internal Medicine, Critical Care Medicine and Infectious Diseases with translational research interests in sepsis and life-threatening infections. He has published over 450 original research manuscripts, reviews/chapters and abstracts.
Ignacio Martin-Loeches, MD, PhD, FJFICMI
Ignacio Martin-Loeches, MD, PhD, FJFICMI is a full-time Consultant in Intensive Care Medicine at St James’s Hospital and Professor at Trinity College, Dublin, Ireland.
He is the Chair of CoBaTrICE (International Competency Based Training programme in Intensive Care Medicine for Europe and other world regions) under the European Society of Intensive Care Medicine (ESICM) and elected council member of the World Federation of Societies of Intensive and Critical Care Medicine. He is part of the Steering committee and executive member of the research-working group of the Surviving Sepsis Campaign (SSC). He is the secretary of the Acute Critical Care Group at the European Respiratory Society (ERS).
He is principal Investigator of European Regional Development Funds (ERDF), Science Foundation Ireland (SFI) grants and the European Network for ICU-related infections (ENIRRIs) under the European Respiratory Society (ERS). He has published over 300 manuscripts in high impact factor journals and his H index is 41.